Hivid (Zalcitabine, ddC)

Brand Name:	Hivid
Generic Name:	Zalcitabine, ddC
The manufacture and distribution of Hivid was discontinued by the manufacturer as of Dec. 31, 2006.
Drug Class:	NRTI

Zalcitabine (Hivid, ddC) (February 27, 2012)
To read PDF, click here.
From AIDS InfoNet
ddC (Hivid) (August 15, 2006)
From AIDS Treatment Data Network
Hivid (Zalcitabine) (November 2005)
To read PDF, click here.
From The Center for AIDS
Drug Interactions: Zalcitabine (August 2004)
From Project Inform
Patient Information About Hivid (Zalcitabine, ddC) (PDF) (September 2002)
From Roche

TheBody.com App for iPhones

My Health Tracker

Medication and Health Reminders

Assess Your Risk for HIV

U.S. ASO Finder

Newly Diagnosed? Words of Encouragement from HIV-Positive Women

HIV Management Today: Mental Health & HIV, the Uncharted Territory

Curing HIV Removes the Scars of the Past

Meth Makes an Ominous Comeback Among Gay Men

Can HIV-Positive People Have Babies? 7 Myths About Pregnancy and HIV/AIDS

More >>

The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.